S
Serac Life Sciences
Privately owned holding company focused on developing innovative molecular imaging technologies
About Serac Life Sciences
Serac Life Sciences is a privately owned holding company dedicated to advancing healthcare through innovative molecular imaging technologies. Its mission is to enhance patient care and quality of life by providing personalized medicine solutions. The company operates through two wholly owned subsidiaries: Serac Healthcare Ltd and Serac Imaging Systems Ltd. Serac Healthcare focuses on developing molecular imaging agents for conditions like endometriosis and inflammatory arthritis, leveraging targeted technologies to improve diagnosis and treatment outcomes. On the other hand, Serac Imaging Systems has developed Seracam, a revolutionary portable hybrid gamma-optical camera designed to bring high-resolution molecular imaging directly to the patient's bedside. This technology aims to transform nuclear medicine workflows by providing efficient, cost-effective imaging solutions that can be used in various healthcare settings, from outpatient clinics to intensive care units. By developing these cutting-edge imaging technologies, Serac Life Sciences is poised to significantly impact the healthcare industry by improving patient access to care, enhancing treatment decision-making, and reducing healthcare costs. The company's commitment to environmental sustainability and social responsibility further underscores its dedication to making a positive impact on both healthcare and society. Serac Life Sciences is open to discussing investment opportunities with like-minded investors who share its vision for advancing healthcare through innovative technologies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- London, United Kingdom
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 41.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, DT and LS, uk is8 life sciences, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2024 | $13M | $52M | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Serac Life Sciences is 2.9K monthly website visits, up 38.1% over the last three months. Serac Life Sciences's team grew 57.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Grow London
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Serac Life Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Serac Life Sciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.